Ervogastat (PF-06865571), a systemically acting diacylglycerol acyltransferase (DGAT2) inhibitor that has advanced into clinical trials for the treatment of non-alcoholic steatohepatitis (NASH) with liver fibrosis.
For research use only. We do not sell to patients.
Name | Ervogastat (PF-06865571) |
---|---|
Iupac Chemical Name | 2-{5-[(3-ethoxypyridin-2-yl)oxy]pyridin-3-yl}-N-[(3S)-oxolan-3-yl]pyrimidine-5-carboxamide |
Synonyms | Ervogastat ; PF 06865571 ; PF-06865571 ; PF06865571 |
Molecular Formula | C21H21N5O4 |
Molecular Weight | 407.42 |
Smile | O=C(C1=CN=C(C2=CC(OC3=NC=CC=C3OCC)=CN=C2)N=C1)N[C@H]4COCC4 |
InChiKey | UKBQFBRPXKGJPY-MRXNPFEDSA-N |
InChi | InChI=1S/C21H21N5O4/c1-2-29-18-4-3-6-23-21(18)30-17-8-14(9-22-12-17)19-24-10-15(11-25-19)20(27)26-16-5-7-28-13-16/h3-4,6,8-12,16H,2,5,7,13H2,1H3,(H,26,27)/t16-/m1/s1 |
CAS Number | 2186700-33-2 |
Related CAS | 2186700-33-2 |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Off-white solid |
---|---|
Purity | ≧98.0% |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
Solubility | Soluble in DMSO |
Handling | Refer to MSDS |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
HS Code | 2934200090 |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |